Home
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
Support
Preclinical Services
Regulatory Support
Supply Chain Solutions
Technologies
High Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Project Support
Share your program stage and we will connect you with the right DempoChem specialist.
CONTACT US
info@dempochem.com
+31 0 10 8009488
About
Contact
Client Portal
Home
Home
Products
Products
Bioactive Compounds
Bioactive Compounds
Protein Kinase Targets
Protein Kinase Targets
c-Met/HGFR
c-Met/HGFR
Home
Home
Products
Products
Bioactive Compounds
Bioactive Compounds
Protein Kinase Targets
Protein Kinase Targets
c-Met/HGFR
c-Met/HGFR
c-Met/HGFR
Products (27)
Zurletrectinib
CAS No.:
2403703-30-8
Capmatinib
CAS No.:
1029712-80-8
Merestinib
CAS No.:
1206799-15-6
Mk-2461
CAS No.:
917879-39-1
Bms-777607
CAS No.:
1025720-94-8
Bms-754807
CAS No.:
1001350-96-4
Capmatinib Hydrochloride
CAS No.:
1865733-40-9
Savolitinib
CAS No.:
1313725-88-0
Glesatinib
CAS No.:
936694-12-1
Pf-04217903
CAS No.:
956905-27-4
Tivantinib
CAS No.:
905854-02-6
Dalmelitinib
CAS No.:
1637658-98-0
Golvatinib
CAS No.:
928037-13-2
Mk-8033
CAS No.:
1001917-37-8
Vebreltinib
CAS No.:
1440964-89-5
Mifanertinib
CAS No.:
1639014-72-4
N~1~-(4-Fluorophenyl)-N'~1~-(4-((2-((2-(morpholin-4-yl)ethyl)carbamoyl)-1H-pyrrolo(2,3-b)pyridin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide
CAS No.:
1021950-26-4
TAM&Met-IN-1
CAS No.:
2412356-57-9
Canlitinib
CAS No.:
2222730-78-9
Terevalefim
CAS No.:
1070881-42-3